# Haemonetics

> Haemonetics makes equipment, single-use supplies and software for plasma and blood collectors and hospitals. Its portfolio spans automated plasma collection, surgical blood recovery, clotting diagnostics, transfusion management and catheter-based vascular closure, with recurring disposable sales supporting a global medical technology business.

- **Founded:** 1971
- **Headquarters:** Boston, United States
- **Founders:** Allen “Jack” Latham Jr. (Founder and inventor)
- **Products:** NexSys PCS, Persona PLUS, NexLynk DMS, Cell Saver Elite+, TEG 6s and TEG Manager
- **Notable:** Latham bowl invention in 1968 preceded the company’s 1971 founding., Introduced Cell Saver in 1974., Completed a NYSE IPO in May 1991 after earlier public and private ownership.

## Products & services

- **NexSys PCS** — Automated plasma collection platform; launched in July 2018. Persona technology personalizes collection, and Express Plus addresses procedure time.
- **Persona PLUS** — Next generation personalized plasma collection technology for NexSys PCS; FDA 510(k) clearance dated February 20, 2026.
- **NexLynk DMS** — Donor management software integrated with plasma collection equipment.
- **Cell Saver Elite+** — Autologous blood recovery equipment that collects, washes and prepares shed surgical blood for return to the same patient. The original Cell Saver system dates to 1974.
- **TEG 6s and TEG Manager** — Hemostasis testing and hospital-network results software to support clinical decisions about coagulation and blood therapy.
- **SafeTrace Tx and BloodTrack** — Transfusion management and blood inventory/bedside workflow software, including integration with Epic.
- **MCS apheresis systems** — Automated blood-component collection systems serving blood centers; original MCS launch was 1992.
- **VASCADE and VASCADE MVP** — Catheter-based vascular closure products for selected arterial and venous access procedures.
- **SavvyWire and OptoWire** — Sensor-guided cardiovascular guidewires added through the OpSens acquisition.
- **ensoETM** — Esophageal temperature management technology acquired with Attune Medical, including protection during radiofrequency cardiac ablation.
- **PerQseal Elite** — Fully bioabsorbable patch-based vascular closure system; received FDA approval for large-bore arterial procedures on October 19, 2026.
- **Training and technical support** — Product education, implementation support, eLearning and technical services for clinical and collection customers.

## Achievements

- Latham bowl invention in 1968 preceded the company’s 1971 founding.
- Introduced Cell Saver in 1974.
- Completed a NYSE IPO in May 1991 after earlier public and private ownership.
- Launched NexSys PCS in July 2018.
- Persona PLUS clearance was supported by a trial involving more than 30,000 donations from nearly 3,000 donors.
- Reported first-quarter fiscal 2027 revenue of $339.4 million, up 5.6% year over year.
- Announced FDA approval of PerQseal Elite for large-bore arterial procedures in October 2026.

## Latest updates

- **2026-10** — October 19: announced FDA approval of PerQseal Elite for large-bore arterial procedures.
- **2026-10** — October 8: CSL announced plans for a U.S. plasma collection network rollout of Haemonetics technology, expected to finish by the end of 2027.
- **2026-08** — August 6: reported Q1 FY2027 revenue of $339.4 million, 5.6% above the year-earlier quarter, and raised full-year guidance.
- **2026-06** — June 5: announced two reportable segments, Apheresis and MedSurg, replacing Plasma, Blood Center and Hospital.
- **2026-02** — February 23: announced FDA clearance of NexSys PCS with Persona PLUS.
- **2026-01** — January 9: acquired Vivasure; announced €100 million upfront consideration with additional contingent consideration of up to €85 million, subject to stated adjustments.

## Links

- Website: https://www.haemonetics.com/
- LinkedIn: https://www.linkedin.com/company/haemonetics
- Twitter/X: https://twitter.com/HaemoneticsCorp
- Facebook: https://www.facebook.com/HaemoneticsCorp

---

Profile page: https://yespress.io/haemonetics
Published by YesPress — https://yespress.io
Last updated: 2026-10-22